Friday 6 November 2026 Export IOVA’s income statement to Excel — free account

Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $263.5 million, up 60.6% from fiscal 2024.

Revenue: +80.1%
EPS: +80.0%
Free cash flow: +89.7%

Quarter to September 2026, against a year earlier

7.99 0.25 +3.23%

Follow IOVA

Alert me

Market cap: $3.5B
P/E: 0.0×
Fwd P/E: −18.9×
Dividend yield: —
F-score: 4/9
Altman Z: −2.30
Beneish M: −2.46
Dividend safety: n/a

Overview

Iovance Biotherapeutics, Inc. (IOVA) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, Iovance Biotherapeutics, Inc. (IOVA) trades at a P/B ratio of 4.3×. Over the past ten years it has ranged from 0.7× (May 2025) to 21.3× (May 2020); the current reading is higher than 68% of that period. That is above the Biotechnology industry median of 2.0× and above the Healthcare sector median of 2.3×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/IOVA/pb-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Iovance Biotherapeutics, Inc. P/B ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/IOVA/metrics/pb-ratio">Iovance Biotherapeutics, Inc. (IOVA) P/B ratio — stockrow.com</a></p>

Period	P/B ratio	Change
FY2025	1.4×	(53.75%)
FY2024	3.0×	(7.31%)
FY2023	3.3×	—

Period	P/B ratio	Change
Sep 2026	8.2×	222.66%
Jun 2026	2.5×	25.01%
Mar 2026	2.0×	45.74%
Dec 2025	1.4×	24.16%
10 more quarters	Free account

Against its own ten years

Low 0.7× High 21.3×

Ten-year median 3.4×

Current reading's percentile 67

Company	P/B ratio
PBLS Parabilis Medicines, Inc. compare	0.8×
ACAD ACADIA Pharmaceuticals Inc. compare	2.6×
XENE Xenon Pharmaceuticals Inc. compare	3.0×
TNGX Tango Therapeutics, Inc. compare	3.1×
ABCL AbCellera Biologics Inc. compare	3.8×
RLAY Relay Therapeutics, Inc. compare	3.9×
IOVA Iovance Biotherapeutics, Inc.	4.3×
IRON Disc Medicine, Inc. compare	4.7×
EWTX Edgewise Therapeutics, Inc. compare	9.4×
Biotechnology industry median	2.0×
Healthcare sector median	2.3×
Market median	1.7×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

Iovance Biotherapeutics, Inc. (IOVA) P/B ratio

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on IOVA

P/B ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/B ratio against peers

What P/B ratio is

More on IOVA

Stockrow Weekly